Receptor-stimulated generation of intracellular reactive oxygen species (ROS) modulates signal transduction, although the mechanism(s) is unclear. One potential basis is the reversible oxidation of the active site cysteine of protein tyrosine phosphatases (PTPs). Here, we show that activation of the antigen receptor of T cells (TCR), which induces production of ROS, induces transient inactivation of the SH2 domain-containing PTP, SHP-2, but not the homologous SHP-1. SHP-2 is recruited to the LATGads-SLP-76 complex and directly regulates the phosphorylation of key signaling proteins Vav1 and ADAP. Furthermore, the association of ADAP with the adapter SLP-76 is regulated by SHP-2 in a redox-dependent manner. The data indicate that TCR-mediated ROS generation leads to SHP-2 oxidation, which promotes T-cell adhesion through effects on an SLP-76-dependent signaling pathway to integrin activation.
Introduction
Regulation of cellular functions in response to exogenous stress, for example, oxidative stress, irradiation, etc., has been characterized in evolutionarily conserved systems from microbial organisms to plants and mammals. It is now clear that cell surface receptors also utilize changes in redox balance to regulate signal transduction. Receptor stimulation with ligands as diverse as PDGF (Meng et al, 2002) , insulin (Mahadev et al, 2001) or angiotensin II (Ushio-Fukai et al, 1998) induces the intracellular production of reactive oxygen species (ROS). In these studies, ROS function as requisite second messengers, regulating protein kinase activation, gene expression and/or proliferative responses. The mechanism(s) for this redox-dependent regulation of biologic responses, however, remains unclear.
One redox-sensitive target that regulates signaling is the family of protein tyrosine phosphatases (PTPs), which have an oxidation-sensitive, active site cysteine . Insulin-induced ROS generation leads to oxidative inactivation of the PTPs, PTP1B and TC45 (Mahadev et al, 2001; Meng et al, 2004) . Both phosphatases control phosphorylation of the insulin receptor or associated proteins, and insulin-induced PTP oxidation regulates downstream signaling. Oxidative inactivation of PTPs was also induced by ROS generation associated with stimulation with EGF (PTP1B) (Lee et al, 1998) or PDGF (LM-PTP, SHP-2, PTEN) (Chiarugi et al, 2001; Meng et al, 2002; Kwon et al, 2004) and this is a pivotal step in the biological effects of these ligands.
Previous studies have shown that signal transduction through the antigen receptor of T cells (TCR) can also be regulated by receptor-mediated production of ROS (Jackson et al, 2004) . In mature T cells, TCR crosslinking induces rapid (within 2-4 min) ROS generation and the data indicate that TCR-stimulated ROS production regulates activation of MAPK, cytokine secretion and gene expression (Devadas et al, 2002; Kwon et al, 2003) . In particular, TCR-induced production of hydrogen peroxide selectively inhibits activation of the MEK/Erk pathway (Kwon et al, 2003) . However, the mechanisms by which ROS regulate TCR signaling are still poorly understood. Exposure to exogenous oxidants leads to oxidative inactivation of PTPs in T cells (O'Shea et al, 1992) , but there is no evidence to date on the effects of TCR-induced ROS production on PTP function.
TCR signaling depends upon coordinated interactions of multiple signaling pathways, including PTPs, protein kinases and adapter proteins (e.g., LAT, SLP-76, Grb2, Gads) that 'nucleate' key proteins (Jordan et al, 2003; Mustelin et al, 2003) . The membrane-localized adapter LAT (linker for activation of T cells), upon tyrosine phosphorylation, recruits a number of proteins via their SH2 domains (e.g., Grb2, Gads, PLCg1) (Wange, 2000) . Gads (Grb2-like adapter downstream of Shc) is an adapter protein that, via one of its SH3 domains, interacts with the proline-rich domain of SLP-76 and recruits it to LAT and the membrane . In addition to the proline-rich domain, SLP-76 (SH2-containing leukocytespecific protein of 76 kDa) has multiple functional interaction domains, including phosphorylated tyrosines and an SH2 domain ) that bind proteins, including Vav1, Nck, Itk and ADAP . ADAP (adhesion-and degranulation-promoting adaptor protein), also known as Fyn SH2-binding protein (Fyb) or SLAP-130, binds the SH2 domain of SLP-76 upon ADAP phosphorylation (Peterson, 2003) . ADAP is necessary for optimal T-cell responses and the inside-out activation of integrins (Griffiths et al, 2001; Peterson et al, 2001) . Thus, the adapters Gads, SLP-76 and ADAP are critical regulators of T-cell development and TCR signaling pathways.
The goal of the current report was to investigate the molecular basis for redox control of TCR signal transduction by intracellular production of ROS. In the current study, we show that SHP-2 is oxidized by ROS produced upon TCR stimulation and that the active site cysteine is the primary site of oxidation. We further identify a site of action for SHP-2 in dephosphorylation of Vav1 and ADAP associated with SLP-76, although it does not dephosphorylate SLP-76 itself. The data support the hypothesis that SHP-2 exerts a negative role in dephosphorylation of ADAP and Vav1, which limits TCRinduced adhesion and LFA-1 clustering. TCR-induced ROS production selectively inhibits SHP-2-mediated dephosphorylation of Vav1 and ADAP associated with SLP-76, leading to redox-dependent changes in TCR-stimulated adhesion and integrin clustering.
Results

TCR-induced oxidation of SHP-2
Our previous data have demonstrated that TCR-induced production of hydrogen peroxide selectively inhibited activation of the MEK/Erk kinase pathway (Kwon et al, 2003; Jackson et al, 2004) . SHP-2 has been shown to promote ERK activation in T cells (Frearson and Alexander, 1998) . Therefore, we analyzed TCR-induced oxidation of SHP-2.
A biotinylated thiol reactive probe was used to label reduced/nonoxidized thiols in whole-cell lysates under anaerobic conditions. The labeling conditions lead to selective alkylation of reactive thiols, such as active site cysteines of PTPs (Kim et al, 2000) . Loss of biotin incorporation into immunoprecipitated SHP-2 indicates oxidation of reactive thiols ( Figure 1A ). Decreased biotin labeling in SHP-2 was detected upon TCR crosslinking in Jurkat T cells ( Figure 1B ) and primary murine T-cell blasts ( Figure 1D ), which occurs coincident with the kinetics of TCR-stimulated ROS generation (Kwon et al, 2003; Jackson et al, 2004) . The loss was transient, however, indicating that TCR-stimulated thiol oxidation was reversible.
To test the selectivity of TCR-induced ROS generation in PTP oxidation, oxidation of SHP-1 was measured. SHP-1 also has tandem SH2 domains, exhibits similar substrate specificity as SHP-2 and has been proposed to affect TCR signal transduction (reviewed in Neel et al, 2003) . Under conditions in which SHP-2 oxidation was observed, little or no oxidation of SHP-1 was detected ( Figure 1C ).
Although the labeling procedure is designed to detect oxidation of the active site cysteine, iodoacetamide could react with other free thiols in SHP-2. Therefore, Jurkat T cells were transfected to express (His) 6 -tagged SHP-2 in which the active site cysteine was mutated to serine (SHP-2(C/S)). Due to the presence of the (His) 6 tag, the ectopically expressed SHP-2 has a slower mobility in gels and can be distinguished from endogenous SHP-2. In unstimulated cells, biotin labeling of endogenous SHP-2 was readily detected, but there was little incorporation of the label into the SHP-2(C/S) protein ( Figure 1E ). The data suggest that the majority of the iodoacetamide labeling of SHP-2, under these conditions, was at the active site. Thus, the transient loss of iodoacetamide labeling in SHP-2 upon TCR stimulation indicates reversible oxidation of the active site cysteine of SHP-2. SHP-2 phosphatase activity was also inhibited under conditions in which thiol oxidation was detected. Using a colorimetric assay (Dechert et al, 1994) , phosphatase activity in SHP-2 immunoprecipitates was decreased upon TCR stimulation in both Jurkat T cells (16.72 to 11.1 pmol/min/10 6 cells) and mouse T-cell blasts (14.35 to 10.72 pmol/min/10 6 cells). The labeling procedure above measures a loss of reactivity in protein thiols under nondenaturing conditions. The results could be affected by accessibility of thiols, and interpretation of the data relies upon the ability to detect decreased biotin incorporation. Therefore, SHP-2 oxidation was assayed using a method in which reduced thiols were blocked under denaturing conditions and the reversibly oxidized thiols were re-reduced and labeled with iodoacetamide-biotin . This 'positive labeling' of oxidized thiols will show a gain of signal upon thiol oxidation induced by TCR-stimulated ROS generation. Consistent with the results in Figure 1 , TCR crosslinking of human T blasts induced a transient oxidation of SHP-2 (Figure 2A ). The level of biotin incorporation was similar to that observed upon treatment of cells with 100 mM exogenous hydrogen peroxide. Under the same conditions, neither TCR stimulation nor treatment with 100 mM hydrogen peroxide induced SHP-1 oxidation. Exposure to 1 mM H 2 O 2 , however, did lead to detectable oxidation of SHP-1 ( Figure 2B ). TCR stimulation in Jurkat T cells also led to marked oxidation of SHP-2 ( Figure 2C ), but not SHP-1 ( Figure 2D ). Thus, TCR-stimulated production of ROS selectively induces oxidation of SHP-2 in T cells.
The two labeling approaches suggested that SHP-2 was more sensitive to intracellular ROS than SHP-1. This was directly tested by exposing Jurkat cells to graded concentrations of hydrogen peroxide and measuring oxidation of both SHP-1 and SHP-2 by the loss of biotin-iodoacetamide incorporation as in Figure 1 (Supplementary Figure 1) . Oxidation of both SHP-1 and SHP-2 is detected, but at least two-to three-fold more hydrogen peroxide is required to detect oxidation of SHP-1.
Antioxidants and antioxidant enzymes were used to indicate a causal role for TCR-induced ROS generation in SHP-2 oxidation. Coincubation of mouse T cells with the antioxidant N-acetyl-cysteine (NAC) inhibited the loss of SHP-2 labeling, suggesting that ROS produced upon TCR stimulation were responsible for the loss of labeling ( Figure 2E ). The presence of NAC also produced a modest increase in biotin labeling of SHP-2 in unstimulated cells, suggesting a basal level of SHP-2 oxidation in cells. To further establish a role for hydrogen peroxide, the antioxidant enzyme peroxiredoxin II (Prx II) was overexpressed in Jurkat T cells. Previous studies have used overexpression of Prx II to eliminate hydrogen peroxide produced upon TCR stimulation (Devadas et al, 2002) . As opposed to that observed in vector-transfected cells, TCR stimulation of cells overexpressing Prx II did not show decreased incorporation of biotin into SHP-2 ( Figure 2F ). The data indicate that TCR-induced production of hydrogen peroxide leads to transient oxidation of SHP-2.
Expression of inactive SHP-2 in T cells
The active site mutant of SHP-2 (SHP-2(C/S)) was expressed in cells to mimic the conditions in which SHP-2 was oxidatively inactivated. Expression of such mutated PTPs has also been used to identify potential phosphatase substrates (Neel and Tonks, 1997) . Overexpression of wild-type SHP-2 (SHP-2 WT) was used to control for the effects of increased SHP-2 protein and the possible effects of increased SHP-2 activity in cells. Anti-HA immunoprecipitation from anti-CD3-stimulated cells expressing HA-tagged SHP-2(C/S) showed increased association of multiple phosphoproteins ( Figure 3A ). The literature suggests that some of these SHP-2-associated proteins may be LAT (Frearson and Alexander, 1998) , Vav1 (Wakino et al, 2004) and/or Gab2 (Yamasaki et al, 2001) . The presence of LAT and the adapter protein ADAP in the anti-HA immunoprecipitates was confirmed by Western blot ( Figure 3A) . The current results and previous reports support an interaction of SHP-2 with LAT and the multiprotein complex formed around LAT. Therefore, to investigate the potential implications of SHP-2 oxidation, the effect of SHP-2(C/S) expression was examined on TCR signaling in and around the complexes dependent upon LAT and SLP-76.
Immunoprecipitation of LAT from Jurkat cells transfected to express SHP-2(C/S) and SHP-2 WT showed minor changes in associated phosphoproteins upon stimulation with anti-CD3 ( Figure 3B ). In these studies, the level of SHP-2(C/S) or ectopically expressed SHP-2 WT was titered to avoid overwhelming the system ( Figure 3C ). There was a modest increase in signals from phosphoproteins comigrating with SLP-76, Vav1 and ADAP in cells expressing SHP-2(C/S). There were no apparent changes in phosphorylation of LAT or ZAP-70, suggesting a selective effect. Immunoblots suggested that the minor increases in the phosphotyrosine signal in Vav1 were not mirrored by changes in Vav1 protein associated with LAT, but SLP-76 protein levels in the immunoprecipitates did show similar increases as in the phosphotyrosine blot ( Figure 3D ). In general, expression of wild-type SHP-2 did not markedly change either phosphorylation or levels of proteins co-immunoprecipitating with LAT.
Grb2 and Gads are the major adapter proteins that bind LAT. Grb2 immunoprecipitates showed minor differences in the association of tyrosine phosphorylated proteins in cells expressing either wild-type or mutant SHP-2 ( Figure 3E and F). There was an increased intensity in the phosphotyrosine blot for a band that comigrated with Vav1, although there was no change in Vav1 protein in the immunoprecipitates by immunoblot. Thus, expression of the inactive SHP-2(C/S) induced small changes in phosphorylation and association of proteins with LAT, and the effect(s) does not appear to be centered upon proteins known to be associated with Grb2.
Effect of SHP-2(C/S) on Gads-and SLP-76-associated proteins
Analysis of phosphoproteins that co-immunoprecipitated with Gads from TCR-stimulated cells expressing SHP-2(C/S) extended the results observed in LAT precipitates. There was an increase (approximately two-fold by densitometry) in tyrosine phosphorylation of bands corresponding to ADAP and Vav1 as compared to cells expressing SHP-2 WT or vector ( Figure 4A and Supplementary Figure 2A) . In both cases, overexpression of SHP-2 WT led to small decreases in phosphorylation of the proteins as compared to vector control cells. Immunoblot for total ADAP protein showed commensurate changes in ADAP protein ( Figure 4A ). The data are consistent with the model of SHP-2 regulating binding of phosphorylated ADAP to SLP-76. The changes in Vav1 phosphorylation, however, were not reflected by increased Vav1 protein associated with Gads ( Figure 4A ). These results were consistent with the model of the SH2 domain of Vav1 binding to phosphorylated SLP-76, and SHP-2 acting to dephosphorylate Vav1. Identical results were observed in SLP-76 immunoprecipitates ( Figure 4B and Supplementary Figure 2B) . The effects of SHP-2 were selective in that total protein and tyrosine phosphorylation of both SLP-76 and LAT and association of other proteins including PLCg1 were largely unchanged by expression of either active site mutant or wild-type SHP-2. These results suggested that SHP-2 dephosphorylated proteins associated with SLP-76, but did not target SLP-76 itself. The data further suggest that Vav1 and ADAP are SHP-2 substrates and SHP-2 regulates their activation and/or association with SLP-76.
The consistent effect on Vav1 phosphorylation led us to measure directly changes in Vav1 phosphorylation in Vav1 immunoprecipitates ( Figure 4C ). Vav1 has multiple possible phosphorylation sites, and SHP-2(C/S) expression induced a modest increase in total Vav1 phosphorylation. When analyzed with a phosphospecific antibody to tyrosine 174 (Vav1 Y174), however, the presence of SHP-2(C/S) showed an increase (greater than 50% over vector control) in Vav1 phosphorylation. Thus, SHP-2 activity seems to have a selective effect on the phosphorylation of Vav1 at tyrosine 174, which is critical in activation of Vav1 GEF function (Turner and Billadeau, 2002) .
Direct immunoprecipitation of ADAP supported the observation that SHP-2(C/S) expression led to increased ADAP phosphorylation ( Figure 4D ). These data further substantiate the model of SHP-2 regulating ADAP-SLP-76 association. Immunoprecipitation of Gads from anti-CD3-stimulated SLP-76-deficient Jurkat cells (J.14) did not show evidence of Vav1 and low levels of ADAP in Gads immunoprecipitates (Supplementary Figure 2C) . Co-immunoprecipitation of SHP-2 with Gads, on the other hand, was largely unchanged in J.14 cells.
The SH2 domains of SHP-2 and SHP-1 show selective recognition, and are generally not interchangeable (Neel et al, 2003) . Nevertheless, expression of high levels of SHP-2(C/S) might alter SHP-1 function. To test the potential role of SHP-1 in TCR-mediated changes in phosphorylation of proteins in the Gads-SLP-76 complex, SHP-1(C/S) was expressed side by side with SHP-2(C/S) in Jurkat cells (Supplementary Figure 3) . In cells expressing SHP-1(C/S), anti-SLP-76 immunoprecipitates did not show the increase in phosphorylated Vav1 or phospho-ADAP that was observed in cells expressing SHP-2(C/S). In contrast, there was decreased phosphorylation of bands corresponding to ADAP, LAT and Vav1.
Therefore, the data support a model in which SHP-2 associates with a Gads-SLP-76 complex but does not target SLP-76 itself as a substrate. The data suggest that SHP-2 controls phosphorylation of Vav1 bound to SLP-76 and regulates the phosphorylation of ADAP and therefore its association with SLP-76.
Role of ROS in protein association with Gads-SLP-76
SHP-2(C/S) was expressed to mimic oxidatively inactivated SHP-2 in cells where ROS generation was occurring. Quenching TCR-induced ROS production with antioxidants, which inhibited SHP-2 oxidation (Figure 2) , should show the opposite effect produced by SHP-2(C/S) expression. Thus, the effects of Prx II overexpression in TCR-stimulated Jurkat T cells were analyzed in immunoprecipitates of both Gads and SLP-76 ( Figure 5 ). As was suggested by our previous findings (Kwon et al, 2003) , overall anti-CD3-induced tyrosine phosphorylation was not markedly affected by Prx II overexpression as measured in total cell lysates (Supplementary Figure  4A) . In Gads ( Figure 5A ) and SLP-76 ( Figure 5B ) immunoprecipitates, anti-CD3-induced ADAP phosphorylation and association were decreased nearly two-fold in cells expressing Prx II as compared to vector control. Direct immunoprecipitation of ADAP confirmed these observations, as Prx II overexpression inhibited TCR-stimulated phosphorylation of total ADAP ( Figure 5C ). As above, these effects were selective since phosphorylation of SLP-76 and association of proteins such as PLCg1 were not affected by expression of Prx II. In contrast, the results with Vav1 in Prx II-overexpressing cells were not the converse of those with SHP-2(C/S). Vav1 phosphorylation and Vav1 protein levels in Gads immunoprecipitates showed little to no change as compared to vector control ( Figure 5A ). Thus, redox regulation of Vav1 phosphorylation in Gads-SLP-76 complexes appears to be multifaceted. The data clearly show that tyrosine phosphorylation of ADAP and its association with SLP-76 are influenced by ROS, potentially through oxidation of SHP-2.
The effects of Prx II ( Figure 5A ) or SHP-2(C/S) ( Figure 4A ) on SLP-76-ADAP association might result from redox regulation of SHP-2 localized with the Gads-SLP-76 complex. Cotransfection to express both SHP-2(C/S) and Prx II showed an intermediate effect as compared to either protein alone. Levels of ADAP protein co-immunoprecipitating with SLP-76 were nearly 2.5-fold less in cells coexpressing Prx II and SHP-2(C/S) as compared to that observed in cells expressing SHP-2(C/S) alone ( Figure 5D ). The formation of an SLP-76-ADAP complex in cells expressing both proteins was still almost twice as much as in vector control cells as compared to the effects of Prx II alone, which was two-fold less than vector control ( Figure 5A ). Similarly, levels of SHP-2 in SLP-76 immunoprecipitates from cells expressing both SHP-2(C/S) and Prx II were half that in cells expressing the mutant SHP-2 alone, although the levels were still considerably higher than that observed in vector control. The data suggest that localized changes in redox balance control the availability of active SHP-2 to the Gads-SLP-76 signaling complex.
Effects of ROS and SHP-2 on adhesion
ADAP association with SLP-76 has been proposed to regulate TCR-induced adhesion of T cells through inside-out signaling to b-integrins (Griffiths et al, 2001; Peterson et al, 2001) . Using adhesion to fibronectin-coated plates, SHP-2(C/S) expression significantly increased TCR-stimulated adhesion ( Figure 6A ). In contrast, overexpression of SHP-2 WT or Prx II, both of which lead to increased functional SHP-2 in TCRstimulated cells, significantly inhibited adhesion.
Inside-out signaling to integrins involves TCR-stimulated clustering of LFA-1 (Peterson, 2003) . Fluorescent microscopic analysis of LFA-1 in T cells expressing SHP-2(C/S) or Prx II supported the adhesion data ( Figure 6B ). TCR crosslinking induced clustering of LFA-1 and this was significantly augmented in cells expressing SHP-2(C/S) and it was significantly inhibited in cells overexpressing Prx II ( Figure 6C ). Thus, redox regulation of SLP-76-ADAP association is reflected by changes in integrin activation and adhesion of TCR-stimulated cells (Figure 7 ).
Discussion
Appropriate signal transduction and optimal cell activation require a balance between the activity of protein tyrosine kinases and PTPs. Recent evidence has shown that receptormediated generation of ROS can act to fine-tune this balance (Finkel, 2003) . Herein, we show that the PTP SHP-2, but not the highly homologous SHP-1, is transiently oxidized in T cells by TCR-stimulated generation of ROS. Furthermore, we have identified two putative SHP-2 substrates, ADAP and Vav1, in T cells. The data suggest that SHP-2 oxidation promotes TCR-induced phosphorylation of ADAP and Vav1 in the Gads-SLP-76 complex and these changes increase integrin clustering and T-cell adhesion.
Signal transduction by ligands such as EGF, PDGF or insulin leads to generation of intracellular ROS and redox regulation of PTP function (Rhee et al, 2005) . TCR-stimulated ROS production induced oxidation of SHP-2, primarily at the active site cysteine. SHP-2 oxidation was transient, returning to baseline within 15-30 min after stimulation. Oxidative inactivation of PTPs by ROS can be reversible or irreversible, depending upon the oxidation state (Claiborne et al, 1999) . Enzymatic reduction of the active site thiol by glutaredoxin or thioredoxin can lead to recovery of phosphatase activity (Lee et al, 1998; Barrett et al, 1999) . Using positive labeling, SHP-2 was found to have DTT-reducible form(s) of oxidized thiols upon TCR-induced ROS generation. Based upon previous reports of cysteine oxidation in PTPs, these may include sulfenic acids or disulfides formed with nearby intraprotein thiols or glutathione (Rhee et al, 2005) . Recently, it has been shown that, upon oxidation of the active site thiol, PTP1B formed a novel intraprotein cyclic sulfenyl amide (Salmeen et al, 2003; van Montfort et al, 2003) . These modifications are important because they are reversible and protect the active site thiol from further irreversible oxidation.
It appears that oxidation of SHP-2 is somewhat selective in T cells. SHP-1, the only other known mammalian PTP with tandem SH2 domains (Neel et al, 2003) , was not detectably oxidized upon TCR stimulation and required higher amounts of exogenous hydrogen peroxide to demonstrate similar levels of thiol oxidation as SHP-2. Interestingly, PDGF-stimulated ROS generation also induced oxidation of SHP-2, but not SHP-1 (Meng et al, 2002) . This may be due to different spatial orientation of the active site cysteines in relationship to positively charged residues in the active site pocket of the two phosphatases (Groen et al, 2005) . The results may also reflect selective oxidation of PTP(s) present in a specific subcellular fraction by localized production of ROS. Consistent with this model, PDGF-induced SHP-2 oxidation did not occur in cells expressing a mutated PDGF receptor that was unable to recruit SHP-2 (Meng et al, 2002) .
The current data suggest that SHP-2 associates with SLP-76 upon TCR stimulation and oxidized SHP-2 is localized within the Gads-SLP-76 complex. Association of inactive SHP-2 with proteins may be due to prolonged binding to phosphorylated substrates (Frearson and Alexander, 1998; Meng et al, 2002) . In cells expressing the inactive SHP-2(C/S), both anti-Gads and anti-SLP-76 immunoprecipitates showed increased SHP-2 association. Similarly, immunoprecipitation of HA-SHP-2 (C/S) also revealed a limited association of SHP-2 with tyrosine phosphorylated proteins primarily involved in a LAT-Gads-SLP-76 complex.
Coexpression of SHP-2(C/S) and Prx II suggested localized redox regulation of SHP-2, since combined expression partially reversed the effect of either one alone. Thus, expressing SHP-2(C/S) to inhibit/compete for the increased levels of active SHP-2 produced by expression of Prx II led to increased ADAP phosphorylation and SLP-76 association when compared to vector controls or cells expressing Prx II alone. Conversely, inhibiting localized oxidation of SHP-2 with Prx II expression increased the amount of active SHP-2 in the Gads-SLP-76 complex. This competed with inactive SHP-2(C/S), dephosphorylated ADAP and decreased ADAP-SLP-76 binding. Therefore, the data suggest that changes in redox balance control the association of SHP-2 with the Gads-SLP-76 complex and its ability to dephosphorylate substrate proteins.
The interactions that lead SHP-2 to be recruited to SLP-76 are, as of yet, unclear. In SLP-76-deficient cells, co-immunoprecipitation of SHP-2 with Gads appeared unaffected, suggesting that SLP-76 itself or proteins recruited to Gads via SLP-76 (Vav1, Nck, Itk) did not recruit SHP-2 to the complex. A major SHP-2-binding protein is the adapter Gab2 (Yamasaki et al, 2001) , which binds the SH3 domains of Grb2 and Gads (Yamasaki et al, 2003) . In our hands, Gab2 was not detected in Grb2 immunoprecipitates (data not shown), while association with Gads was readily detected. Gab2 and SLP-76 were shown to compete for binding to the C-terminal SH3 domain of Gads (Yamasaki et al, 2003) , while it is unclear if any proteins bind the N-terminal SH3 domain of Gads . Therefore, in our working model (Figure 7 ), SHP-2 is brought in proximity to substrate proteins in the LAT-Gads-SLP-76 complex via binding of its SH2 domains to phosphorylated tyrosines in Gab2, which is bound to another Gads molecule interacting with the same or neighboring phosphorylated LAT.
Despite its proximity to many proteins in the Gads-SLP-76 complex, the effects of SHP-2 and ROS are selective. Phosphorylation or co-immunoprecipitation of proteins such as SLP-76 itself and PLCg1 was not affected by expression of SHP-2(C/S) or by removing ROS with Prx II. Because Gads and PLCg1 promote association of SLP-76 with LAT (Houtman et al, 2004) , the data suggest that SHP-2 does not affect formation of the multi-adapter complex (LAT-Gads-SLP-76) but does selectively dephosphorylate proteins bound to that complex. The findings suggest that Vav1 and ADAP are direct substrates of SHP-2. Phosphorylation of total ADAP and total Vav1 was augmented by expression of SHP-2(C/S), and if only the pools of Vav1 or ADAP that were associated with Gads-SLP-76 were analyzed, this effect was magnified. These data support the notion of a localized and selective effect of SHP-2 on proteins in the Gads-SLP-76 complex upon TCR triggering.
Our findings are further supported by a recent report that SHP-2 regulates Vav1 phosphorylation and Rho activation in rat aortic smooth muscle cells (Wakino et al, 2004) . Y174 in Vav1 contributes to maintenance of a closed or inactive conformation for Vav1, and mutation of this residue leads to a constitutively active protein with transforming activity (Turner and Billadeau, 2002) . Thus, SHP-2 localization to SLP-76 may control the activation of Vav1 bound to phosphorylated SLP-76, inhibiting subsequent activation of Rho family proteins, Rho, Rac1/2 or cdc42. It is not clear why Prx II expression did not further inhibit Vav1 phosphorylation. Vav1 has multiple phosphorylation sites whose phosphorylation may be affected by other redox-sensitive elements. In contrast to Vav1, tyrosine phosphorylation of ADAP promotes binding to the SH2 domain in SLP-76 (Peterson, 2003) . There is still some controversy as to which tyrosine(s) mediates ADAP-SLP-76 association (Raab et al, 1999; Boerth et al, 2000) . All the same, decreased SHP-2 activity, either through expression of SHP-2(C/S) or through ROS generation, promotes co-immunoprecipitation of ADAP with Gads-SLP-76. Conversely, augmenting SHP-2 activity through SHP-2 WT expression or quenching ROS with Prx II inhibited ADAP phosphorylation and co-precipitation with Gads-SLP-76. Thus, association of Vav1 with SLP-76 is SHP-2 independent, while ADAP-SLP-76 binding is sensitive to SHP-2 and changes in redox balance. ADAP appears to be required for TCR-induced clustering of LFA-1 and associated changes in adhesion of antigenstimulated T cells (Peterson, 2003) . Interaction of ADAP with SLP-76 may be required for TCR-induced LFA-1 clustering , although this remains to be demonstrated. ADAP may regulate T-cell adhesion through the adapter SKAP55 (Wang et al, 2003) , or via Ena/VASP family members, which may affect integrin clustering through effects on cytoskeletal elements (Krause et al, 2000) . Because association of ADAP with these proteins is independent of ADAP phosphorylation, redox regulation of ADAP-SLP-76 interactions may be a critical regulatory step in TCR-induced adhesion. Alternatively, Fyn association with ADAP is dependent upon ADAP phosphorylation (Peterson, 2003) , so Fyn recruitment to a Gads-SLP-76 complex may also be altered by changes in redox balance.
The biological role of SHP-2 in T cells has been difficult to ascertain because of the unavailability of SHP-2-deficient lymphocytes (Qu et al, 2001 ). Frearson and Alexander (1998) showed that expression of SHP-2(C/S) inhibited TCR-induced ERK activation, suggesting a positive role for SHP-2 in T cells. Conversely, a negative role for SHP-2 in activation of the PI3K pathway was also proposed in T cells (Yamasaki et al, 2001) . The current data support a negative role for SHP-2 in regulating 'inside-out' signals from TCR stimulation leading to LFA-1 clustering and adhesion. By extension, TCR-induced ROS generation serves to promote TCR signaling in this context.
In conclusion, the current study has identified SHP-2 as a biological target of TCR-induced ROS. A recent report showing integrin-induced association of SHP-2 with the antioxidant enzyme catalase (Yano et al, 2004) suggests that redox regulation may be a common element in signaling pathways and that mechanisms to protect SHP-2 from oxidation have evolved. Furthermore, the data suggest that redox regulation of SHP-2 modulates TCR-induced LFA-1 clustering and adhesion. This implies that endogenous ROS or proinflammatory conditions may promote antigen-induced adhesion and arrest prior to extravasation and recruitment to the periphery. In the case of T cells, the effects may be via modulation of phosphorylation and/or association of key effector proteins within the protein complex formed through the adapters Gads-SLP-76. Thus, based upon the data, we hypothesize that localized production of ROS upon TCR triggering selectively shifts the balance between kinases and phosphatases to modulate T-cell function and immune responses.
Materials and methods
Antibodies and reagents
Antibodies to Fyb/SLAP-130, c-Cbl, SHP-2, Grb2, ZAP-70, SHP-1, Vav1 and Shc were from Transduction Labs/BD-Biosciences (San Jose, CA). Antibodies to Vav1, Cbl, SHP-2, Grb2, Vav1 (pY174) and SHP-1 were from Santa Cruz Biotechnology (Santa Cruz, CA). Antibodies to LAT, SLP 76, Gads, Vav1, Gab2, phosphotyrosine (4G10) and HRP-anti-sheep IgG were from Upstate Biotechnology Inc. (Lake Placid, NY). HA-tagged proteins were immunoprecipitated using the Profound HA-Tag IP/Co-IP Kit (Pierce, Rockford, IL). Anti-human ADAP was provided by Dr G Koretzky (University of Pennsylvania), and polyclonal anti-LAT sera was provided by Dr L Samelson (NICHD, NIH). The mixture of anti-PLCg1 antibodies for immunoblot was from Dr SG Rhee (NHLBI, NIH) and antihuman LFA-1 (TS2/4) serum was provided by Dr L Zhang (University of Maryland School of Medicine). All other chemicals were obtained from Sigma (St Louis, MO) and all cell culture supplies were from Life Technologies (Carlsbad, CA).
Plasmids
Mammalian expression vectors for green fluorescent protein (GFP; EGFP-N1) and Prx II have been described previously (Devadas et al, 2002) . Mammalian expression vectors for wild-type and catalytically inactive SHP-2 (SHP-2 C459S) have been described previously (Yu et al, 2003) . The cDNA from these vectors was subcloned into pcDNA3.1/His and pCMV-HA vectors (Clontech, Palo Alto, CA) to make expression vectors for (His) 6 -tagged-and HA-tagged SHP-2 proteins, respectively. The mammalian expression vector for SHP-1(C/S) has been described previously (Yu et al, 2005) . , which oxidizes SHP-2 present in the Gads-SLP-76 complex. SHP-2 association is independent of SLP-76 and potentially is recruited by another Gads protein bound to the SHP-2 binding adapter Gab2. Oxidation of SHP-2 promotes phosphorylation of ADAP and Vav1, which is translated to increased LFA-1 clustering and T-cell adhesion. (Bottom) In the presence of antioxidants, for example, the effects of ROS are blunted and SHP-2 in the complex remains more active. This leads to less ADAP-SLP-76 association, inhibits LFA-1 clustering and decreases adhesion.
